{
    "clinical_study": {
        "@rank": "11665", 
        "arm_group": [
            {
                "arm_group_label": "Alcohol Injection", 
                "arm_group_type": "Experimental", 
                "description": "Celiac plexus neurolysis by alcohol injection One time administration during surgery 20 ml of alcohol injection on each side of aorta at level of celiac axis"
            }, 
            {
                "arm_group_label": "Placebo Injection", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Celiac plexus injection - placebo injection"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo\n      for pain control in subjects with pancreatic cancer."
        }, 
        "brief_title": "Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control", 
        "completion_date": {
            "#text": "December 2024", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pancreas Cancer", 
            "Biliary Tract Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pancreatic Neoplasms", 
                "Biliary Tract Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Thi is a study of pain control in subjects undergoing surgery for pancreatic or bile duct\n      cancer.\n\n      Subjects undergoing surgery will be randomized to surgery plus celiac plexus neurolysis with\n      ethanol injection versus surgery plus placebo injection.  Subjects will be followed every\n      three months for survivorship or death to assess pain, quality of life measures, and\n      narcotic pain control usage. The primary endpoint of pain control will be determined at one\n      year post surgery.  Subjects are not required to undergo any additional diagnostic testing\n      procedures that are not part of their routine follow-up care."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        This study will be offered to all patients scheduled to undergo open or laparoscopic\n        operative resection of a presumed pancreatic (any location; i.e., head, body, or tail) or\n        distal biliary tract cancer.\n\n          -  Physiologic suitability for major abdominal surgery\n\n          -  Aged 18 years and older\n\n          -  Written informed consent\n\n          -  Ability to understand and comply with study guidelines.\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Previous, preoperative celiac nerve block\n\n          -  Neoadjuvant chemotherapy or radiation therapy\n\n          -  Incomplete tumor resection (R2 resection, grossly positive resection margin)\n\n          -  Presumed ampullary or duodenal cancer based on preoperative work-up or intraoperative\n             findings\n\n          -  Benign tumors, neuroendocrine tumors, soft tissue tumors based on preoperative\n             work-up or intraoperative findings\n\n          -  Known metastatic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002806", 
            "org_study_id": "1011003552"
        }, 
        "intervention": [
            {
                "arm_group_label": "Alcohol Injection", 
                "description": "Celiac plexus neurolysis by alcohol injection", 
                "intervention_name": "Alcohol Injection", 
                "intervention_type": "Other", 
                "other_name": "Ethanol Injection"
            }, 
            {
                "arm_group_label": "Placebo Injection", 
                "intervention_name": "Placebo Injection", 
                "intervention_type": "Other", 
                "other_name": "Normal saline injection"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ethanol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pancreatic cancer", 
            "Pain"
        ], 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "contact": {
                "email": "zhongx@iupui.edu", 
                "last_name": "Xin Zhong, RN", 
                "phone": "317-274-5495"
            }, 
            "facility": {
                "address": {
                    "city": "Indianapolis", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "46202"
                }, 
                "name": "Indiana University"
            }, 
            "investigator": {
                "last_name": "Michael G House, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Trial of Intraoperative Chemical Splanchnicectomy for Patients With Resected Pancreatobiliary Malignancies", 
        "overall_contact": {
            "email": "michouse@iupui.edu", 
            "last_name": "Michael G House, MD", 
            "phone": "317-274-0113"
        }, 
        "overall_contact_backup": {
            "email": "zhongx@iupui.edu", 
            "last_name": "Xin Zhong, RN", 
            "phone": "317-274-5495"
        }, 
        "overall_official": {
            "affiliation": "Indiana University, Department of Surgery", 
            "last_name": "Michael G House, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pain Control", 
            "safety_issue": "No", 
            "time_frame": "12 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002806"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Disease-specific, recurrence-free survival", 
            "safety_issue": "No", 
            "time_frame": "2 Years"
        }, 
        "source": "Indiana University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Indiana University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}